Modulation of Heme-Induced Inflammation Using MicroRNA-Loaded Liposomes: Implications for Hemolytic Disorders Such as Malaria and Sickle Cell Disease
International Journal of Molecular Sciences · 29.11.2023 · 24 (23) · 16934
DOI: 10.3390/ijms242316934 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.11.2023. Verfasst von Alaijah Bashi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Morehouse School of Medicine, Atlanta, GA 30310, USA. Hauptthemen laut MEDLINE: MicroRNAs, Anemia, Sickle Cell, Malaria. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIMHD NIH HHS, FIC NIH HHS.
Abstract (Originalsprache)
Hemolytic disorders, like malaria and sickle cell disease (SCD), are responsible for significant mortality and morbidity rates globally, specifically in the Americas and Africa. In both malaria and SCD, red blood cell hemolysis leads to the release of a cytotoxic heme that triggers the expression of unique inflammatory profiles, which mediate the tissue damage and pathogenesis of both diseases. MicroRNAs (miRNAs), such as miR-451a and let-7i-5p, contribute to a reduction in the pro-inflammatory responses induced by circulating free hemes. MiR-451a targets both IL-6R (pro-inflammatory) and 14-3-3ζ (anti-inflammatory), and when this miRNA is present, IL-6R is reduced and 14-3-3ζ is increased. Let-7i-5p targets and reduces TLR4, which results in anti-inflammatory signaling. These gene targets regulate inflammation via NFκB regulation and increase anti-inflammatory signaling. Additionally, they indirectly regulate the expression of key heme scavengers, such as heme-oxygenase 1 (HO-1) (coded by the HMOX1 gene) and hemopexin, to decrease circulating cytotoxic heme concentration. MiRNAs can be transported within extracellular vesicles (EVs), such as exosomes, offering insights into the mechanisms of mitigating heme-induced inflammation. We tested the hypothesis that miR-451a- or let-7i-5p-loaded artificial EVs (liposomes) will reduce heme-induced inflammation in brain vascular endothelial cells (HBEC-5i, ATCC: CRL-3245) and macrophages (THP-1, ATCC: TIB-202) in vitro. We completed arginase and nitric oxide assays to determine anti- and pro-inflammatory macrophage presence, respectively. We also assessed the gene expression of IL-6R, TLR4, 14-3-3ζ, and NFκB by RT-qPCR for both cell lines. Our findings revealed that the exposure of HBEC-5i and THP-1 to liposomes loaded with miR-451a or let-7i-5p led to a reduced mRNA expression of IL-6R, TLR4, 14-3-3ζ, and NFκB when treated with a heme. It also resulted in the increased expression of HMOX1 and hemopexin. Finally, macrophages exhibited a tendency toward adopting an anti-inflammatory differentiation phenotype. These findings suggest that miRNA-loaded liposomes can modulate heme-induced inflammation and can be used to target specific cellular pathways, mediating inflammation common to hematological conditions, like malaria and SCD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Morehouse School of Medicine, Atlanta, GA 30310, USA.
- Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA 30310, USA.
- Brown Cancer Center, School of Medicine, University of Louisville, Louisville, KY 40202, USA.
- Hepatobiology and Toxicology COBRE, University of Louisville, Louisville, KY 40202, USA.
- Department of Pharmacology & Toxicology, University of Louisville , Louisville, KY 40202, USA.
ORCID-Profile: Joshua L Hood, Winston E Thompson, Jonathan K Stiles, Adel Driss
Förderung
- NIGMS NIH HHS
- NIMHD NIH HHS
- FIC NIH HHS
- NCATS NIH HHS
- NINDS NIH HHS
- National Institutes of Health (NIH)’s Fogarty International Center (FIC)
- NIH/NIMHD Research Centers in Minority Institutions (RCMI)
- National Center for Advancing Translational Sciences of the NIH
Zitieren
APA
Bashi, A., Lekpor, C., Hood, J. L., Thompson, W. E., Stiles, J. K., & Driss, A. (2023). Modulation of Heme-Induced Inflammation Using MicroRNA-Loaded Liposomes: Implications for Hemolytic Disorders Such as Malaria and Sickle Cell Disease. International Journal of Molecular Sciences, 24(23), 16934. https://doi.org/10.3390/ijms242316934
Vancouver
Bashi A, Lekpor C, Hood JL, Thompson WE, Stiles JK, Driss A. Modulation of Heme-Induced Inflammation Using MicroRNA-Loaded Liposomes: Implications for Hemolytic Disorders Such as Malaria and Sickle Cell Disease. International Journal of Molecular Sciences. 2023;24(23):16934. doi:10.3390/ijms242316934
BibTeX
@article{Bashi2023,
author = {Bashi, Alaijah and Lekpor, Cecilia and Hood, Joshua L and Thompson, Winston E and Stiles, Jonathan K and Driss, Adel},
title = {Modulation of Heme-Induced Inflammation Using MicroRNA-Loaded Liposomes: Implications for Hemolytic Disorders Such as Malaria and Sickle Cell Disease},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {23},
pages = {16934},
doi = {10.3390/ijms242316934}
}
EUVIMED